Mild cognitive impairment in relapsing-remitting multiple sclerosis

Mild cognitive impairment in relapsing-remitting multiple sclerosis

Bibliographic Details
Main Authors:	Dimakopoulou Aikaterini, Papamihalis Evaggelos, Petsanis Konstantinos, Floros George, Lagomatis-Lazopoulos George, Varsamopoulou Anastasia, Deretzi Georgia, Grigoriadis Nikolaos
Format:	Article
Language:	English
Published:	BMC 2008-04-01
Series:	Annals of General Psychiatry

Similar Items

Natalizumab for relapsing-remitting multiple sclerosis
by: A. Horga, et al.
Published: (2011-01-01)

Natalizumab for relapsing remitting multiple sclerosis
by: Pucci, Eugenio, et al.
Published: (2011)

Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
by: S. Migliore, et al.
Published: (2017-01-01)

Multiple Sclerosis Relapsing Remitting Progressive Type
by: Nora Fitri, et al.
Published: (2020-12-01)

Advances in the treatment of relapsing - Remitting multiple sclerosis
by: Radu Tanasescu, et al.
Published: (2014-04-01)

Immunomodulatory treatments for relapsing–remitting multiple sclerosis
by: Fritz Leutmezer
Published: (2017-01-01)

Cognitive impairment in relapsing remitting Multiple Sclerosis
by: Saška Roškar
Published: (2003-06-01)

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Burcu Altunrende, et al.
Published: (2017-12-01)

Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability
by: Arzu Ceylan Has Silemek, et al.
Published: (2020-01-01)

The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
by: Georgios Tsivgoulis, et al.
Published: (2015-01-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)

Serum prolactin in patients with relapsing remitting multiple sclerosis
by: Hoda A. Alwakil, et al.
Published: (2020-07-01)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
by: Burgal María, et al.
Published: (2010-04-01)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
by: Julio Sotelo, et al.
Published: (2011-01-01)

Magnetic resonance imaging in relapsing-remitting multiple sclerosis
by: Chard, Declan Tarn
Published: (2007)

Reasoning & health information in relapsing-remitting multiple sclerosis
by: McKniqht, Patrick
Published: (2007)

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
by: Halil Önder
Published: (2019-06-01)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
by: Oliver Findling, et al.
Published: (2018-08-01)

Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis
by: Forooz Peiravian, et al.
Published: (2016-09-01)

Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis
by: Nikolaos Dimisianos, et al.
Published: (2014-01-01)

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
by: Georgios Tsivgoulis, et al.
Published: (2015-01-01)

Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies
by: Kay, Kathleen Alexandra
Published: (2016)

The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis
by: O. A. Traktirskaya, et al.
Published: (2019-03-01)

Systematic review of prediction models in relapsing remitting multiple sclerosis.
by: Fraser S Brown, et al.
Published: (2020-01-01)

Long-term daclizumab therapy in relapsing-remitting multiple sclerosis
by: Monica A. Rojas, et al.
Published: (2009-09-01)

Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
by: Roberto Bomprezzi
Published: (2015-01-01)

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
by: Lugaresi A, et al.
Published: (2013-06-01)

Thalamic–hippocampal–prefrontal disruption in relapsing–remitting multiple sclerosis
by: Kyle C. Kern, et al.
Published: (2015-01-01)

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
by: Romme Christensen Jeppe, et al.
Published: (2012-09-01)

MRI lesion activity in relapsing-remitting patients with multiple sclerosis
by: Zhao, Guo Jun
Published: (2009)

MRI lesion activity in relapsing-remitting patients with multiple sclerosis
by: Zhao, Guo Jun
Published: (2009)

Comparison of first-line therapies for relapsing-remitting multiple sclerosis
by: Yennam, Amulya
Published: (2021)

Cerebellar Information Processing in Relapsing-Remitting Multiple Sclerosis (RRMS)
by: E. Lesage, et al.
Published: (2010-01-01)

Investigation of oxidative stress in relapse and remission periods of patients with relapsing-Remitting multiple sclerosis
by: Samet Oncel, et al.
Published: (2021-01-01)

Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial
by: Lambros Messinis, et al.
Published: (2017-01-01)

Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis
by: Gloria Castellazzi, et al.
Published: (2018-08-01)

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens
by: Maria Rodi, et al.
Published: (2016-08-01)

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
by: Friedemann Paul, et al.
Published: (2008-04-01)

Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis: Understanding Stressors in Patients
by: Ali Khatibi, et al.
Published: (2020-03-01)

Multimodal evoked potential in monitoring activity relapsing and remitting multiple sclerosis
by: Poverennova I.E., et al.
Published: (2018-03-01)

Cannot write session to /tmp/vufind_sessions/sess_jggnlostdvg7fmhk2usauss3u0